Search for Clinical Trial Results

Paraganglioma, Extra-Adrenal - 25 Studies Found
Status | Study |
Completed |
Study Name: RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid Condition:
|
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition:
|
Withdrawn |
Study Name: Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma Condition:
Date: 2013-09-10 Interventions:
|
Recruiting |
Study Name: Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions Condition:
|
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition:
|
Not yet recruiting |
Study Name: Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery Condition:
|
Available |
Study Name: Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma Condition:
Date: 2016-11-08 Interventions: Drug: Ultratrace Iobenguane I131 Subjects will receive a dosimetry dose of AZEDRA and will undergo 3 who |
Recruiting |
Study Name: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers Condition:
|
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition:
|